Načítá se...
Therapeutic Advances and New Directions for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a molecularly diverse grouping with poor prognosis for which chemotherapy remains the foundation of treatment. The molecular heterogeneity of the disease rationalizes its diverse biological behavior and differential response to treatment. Estimates of up to 20...
Uloženo v:
| Vydáno v: | Breast Care (Basel) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger GmbH
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5465752/ https://ncbi.nlm.nih.gov/pubmed/28611537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000455821 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|